• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16493 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     Quality Improvement Scotland (NHS QIS ) Immunosuppressive therapy for renal transplantation in adults
2004     NIHR Horizon Scanning Centre (NIHR HSC) FibroTest-ActiTest, a diagnostic test for liver fibrosis in patients with hepatitis C - horizon scanning review
2004     HAYES, Inc. Percutaneous vertebroplasty and kyphoplasty
2004     Quality Improvement Scotland (NHS QIS ) Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours
2004     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Are tailor-made drugs just around the corner? Abridged version of the TA-SWISS study 'Pharmacogenetics and Pharmacogenomics'
2004     HAYES, Inc. Photodynamic therapy for actinic keratoses
2004     Quality Improvement Scotland (NHS QIS ) Comparison of digital mammography and film screen mammography
2004     Quality Improvement Scotland (NHS QIS ) Treatments for opiate dependence
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sildenafil citrate for adult pulmonary arterial hypertension - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Bivalirudin for percutaneous coronary interventions (PCI) - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sacrosidase (Sucraid) for congenital sucrase-isomaltase deficiency - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Nitisinone for hereditary tyrosinaemia type 1 (HT-1) - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Miglustat for type 3 Gaucher's, Niemann-Pick type C and lateonset Tay-Sachs disease - horizon scanning review [withdrawn]
2004     Agency for Healthcare Research and Quality (AHRQ) Screening for bladder cancer
2004     NIHR Horizon Scanning Centre (NIHR HSC) StaphVAX for the prevention of Staphylococcus aureus infections in end stage renal disease - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Cinacalcet HCl for secondary hyperparathyroidism - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Cinacalcet for secondary hyperparathyroidism
2004     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab for psoriasis - horizon scanning review
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Duloxetine for major depressive disorder and stress urinary incontinence
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Insulin glargine for type 2 diabetes
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers
2004     HAYES, Inc. Positron emission tomography (PET) for Huntington's disease (HD)
2004     Agency for Healthcare Research and Quality (AHRQ) Measuring the quality of breast cancer care in women
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Home-based chemotherapy for cancer: issues for patients, caregivers and the health care system
2004     Agency for Healthcare Research and Quality (AHRQ) Training of hospital staff to respond to a mass casualty incident
2004     VA Technology Assessment Program (VATAP) Surgical robotics
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological and surgical treatment of obesity
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Nitric oxide measurement system (NIOX) for monitoring response to asthma treatment
2004     VA Technology Assessment Program (VATAP) Outcome measurement in major depression (Number 3 in a Series: Outcome measurement in VHA mental health services)
2004     New Zealand Health Technology Assessment (NZHTA) What is the evidence for the effectiveness of managing the hospital/community interface for older people? A critical appraisal of the literature
2004     New Zealand Health Technology Assessment (NZHTA) Evidence based review of medicines for sexual dysfunction in men: a report commissioned by the New Zealand Accident Compensation Corporation (ACC)
2004     New Zealand Health Technology Assessment (NZHTA) Evidence based review of medicines for sexual dysfunction in females: a report commissioned by the New Zealand Accident Compensation Corporation (ACC)
2004     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
2004     NIHR Health Technology Assessment programme Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation
2004     HAYES, Inc. Positron emission tomography (PET) for Parkinson's disease
2004     NIHR Health Technology Assessment programme Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Cryotherapy for prostate cancer
2004     NIHR Health Technology Assessment programme Methods for identifying and classifying surgical site infection after discharge from hospital
2004     Finnish Office for Health Care Technology Assessment (Finohta) [Screening for rare metabolic disease in newborn infants]
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Quantitative approaches to patient safety. Research in risk analysis and risk management as applied to radiotherapy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Diabetic testing
2004     Alberta Heritage Foundation for Medical Research (AHFMR) A selected inventory of abstracts of Cochrane reviews on physiotherapy/physical therapy - interim report for expert advisory panel and the research team
2004     New Zealand Health Technology Assessment (NZHTA) What is the evidence for the effectiveness of behavioural and skill-based early intervention in young children with autism spectrum disorder (ASD)?
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) EMDR for treatment of post-traumatic stress disorder
2004     NIHR Health Technology Assessment programme Involving South Asian patients in clinical trials
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Endometrial ablation for menorrhagia
2004     NIHR Health Technology Assessment programme The value of a QALY implied by the value of a 'statistical life' in the field of transport
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Interventional and intraoperative magnetic resonance imaging
2004     HAYES, Inc. Postoperative disposable ambulatory regional anesthesia
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Insulin pen-fill formulations
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Profile of an HTA program: the AHFMR Health Technology Assessment Unit, 2002-2003
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Patient lift technologies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Misoprostol in pregnancy
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Prolotherapy for the treatment of chronic musculoskeletal pain
2004     Malaysian Health Technology Assessment Unit (MHTAU) Screening for hearing loss in infants
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thalidomide for the treatment of multiple myeloma
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for hearing loss in high risk babies
2004     Malaysian Health Technology Assessment Unit (MHTAU) Second generation endometrial ablation
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Second generation endometrial ablation techniques
2004     NIHR Health Technology Assessment programme The relative societal value of health gains for different beneficiaries
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Advance directives for end-of-life care in the elderly - effectiveness of delivery modes
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Use of ultrasound in antenatal and primary care
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Low level laser therapy for wound healing: an update
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for obesity in young population
2004     HAYES, Inc. Proton beam therapy
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prefabricated myo-functional appliance for treatment
2004     HAYES, Inc. Proton beam therapy for prostate cancer
2004     Agency for Healthcare Research and Quality (AHRQ) Meta-regression approaches: what, why, when, and how?
2004     ECRI B-type natriuretic peptide for diagnosing heart failure
2004     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: a critical analysis of quality improvement strategies, volume 1 - series overview and methodology
2004     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: a critical analysis of quality improvement strategies, volume 2 - diabetes mellitus care
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Use of cannabis or cannabinoids for non-malignant chronic pain
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Living donor liver transplantation in children
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Botulinum toxin type A injection for achalasia and anal fissure
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Botulinum toxin type A injection into the ilopsoas muscle
2004     HAYES, Inc. Radiofrequency ablation for chronic spinal pain
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Adult to adult living donor liver transplantation
2004     HAYES, Inc. Radiofrequency ablation for osteoid osteoma
2004     HAYES, Inc. Radiofrequency ablation for primary and metastatic cancers of the liver
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Standard quality assessment criteria for evaluating primary research papers from a variety of fields
2004     HAYES, Inc. Radiofrequency ablation for trigeminal neuralgia
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Knowledge brokers: linking researchers and policy makers
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological treatment of dementia
2004     HAYES, Inc. Radiofrequency endometrial ablation for menorrhagia secondary to dysfunctional uterine bleeding
2004     University of York Effectiveness of antihypertensive drugs in black people
2004     Medical Advisory Secretariat (MAS) Bispectral index monitor: an evidence-based analysis
2004     Medical Advisory Secretariat (MAS) Primary angioplasty for the treatment of acute ST-segment elevated myocardial infarction: an evidence-based analysis
2004     NIHR Health Technology Assessment programme Identification and assessment of ongoing trials in health technology assessment reviews
2004     National Institute for Health and Care Excellence (NICE) Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours. NICE technology appraisal guidance 86
2004     NIHR Health Technology Assessment programme Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine
2004     NIHR Health Technology Assessment programme Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis
2004     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation
2004     HAYES, Inc. Recombinant human bone morphogenetic protein for use in bone repair
2004     NIHR Health Technology Assessment programme Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis
2004     HAYES, Inc. Robotically assisted coronary artery bypass surgery
2004     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Evaluation of photodynamic therapy for the treatment of exudative age-related macular degeneration (ARMD) with subfoveal neovascularization